Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PFQU | ISIN: US6748705067 | Ticker-Symbol: RUOC
Tradegate
24.01.25
21:56 Uhr
0,823 Euro
+0,025
+3,13 %
1-Jahres-Chart
OCEAN POWER TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
OCEAN POWER TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,7780,80924.01.
0,7790,81324.01.
ACCESS Newswire
431 Leser
Artikel bewerten:
(2)

Paragon Technologies Inc.: Paragon Calls on Ocean Power to Cease Any and All Future Equity Raises That Dilute Existing Stockholders to Fund OPT's Losses and Executive Compensation

Finanznachrichten News

Paragon Commits Up to $3 Million in Non-Dilutive Preferred Equity of OPT to Save the Company from Insolvency and Future Shareholder Losses.

EASTON, PA / ACCESSWIRE / April 22, 2024 / Paragon Technologies, Inc. ("Paragon"), a diversified holding company and the largest shareholder of Ocean Power Technologies, Inc. (NYSE American:OPTT), ("Company" or "OPT"), calls on OPT to immediately cease any future dilutive equity issuance and instead engage with Paragon to save OPT shareholders from a total loss and the company from permanent financial ruin.

"Since OPT concluded what we believe may have been an invalid annual meeting on February 28, OPT's share price has nosedived, down nearly 40%" notes Sham Gad, Chairman of Paragon. "The market has lost any faith in CEO Philip Stratmann's strategy because it simply is not working at all."

Continues Gad, "Over the past few weeks OPT has issued several press releases announcing various partnerships and the market response has been the same - a significant drop in the share price. Shareholders and other investors have lost all faith in the competency of OPT's executives and directors to deliver shareholder value."

On April 12, Paragon issued a public release announcing that they filed a complaint in the Chancery Court in Delaware alleging that OPT failed to achieve a quorum and therefore a valid annual meeting was not held. Two business days later, April 16th, over 9 million shares of OPTT traded as the stock declined 10 percent. We believe the excessive volume was due to OPT rushing to raise capital either because the Company is facing a liquidity crunch or raising cash from shareholders to fund its potential defense of Paragon's annual meeting allegations. Since that time, OPT's share price has continued to experience precipitous declines.

Today, Paragon Technologies is announcing its willingness to invest up to $3 million in non-dilutive preferred equity in OPT to save the Company from likely insolvency and put the company on a path to finally delivering value for shareholders.

"From day one Paragon has been fully committed to doing what is best for OPT shareholders and we are demonstrating that now by our willingness to put more money into the Company," states Gad. "Our investment will require our direct involvement in the oversight of OPT, but that is a given considering the value destruction that has occurred in recent years. Instead of diluting shareholders and paying a fee of 3 percent to do so, we are prepared to put real money into OPT and do so quickly."

By choosing to issue dilutive equity at punishing prices and paying an unnecessary fee to bankers instead of working with Paragon as source of capital, OPT's Board is telling shareholders that it prefers to raise money in the market that serves to destroy value for existing shareholders while the Board and CEO continue to collect extraordinary compensation relative to OPT's size and performance.

We urge the OPT Board to begin immediate discussions with Paragon. We encourage all OPT directors and officers to carefully consider their risks related to continuing with corporate actions that result in significant market declines and destruction of shareholder value rather than pursuing better alternatives being presented to them by Paragon.

Please email us with any questions at ir@pgntgroup.com.

SOURCE: Paragon Technologies, Inc.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.